(Q35214564)

7 August 2017

1 reference

title

Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella (English)

1 reference

7 August 2017

1 reference

1 reference

1 reference

1 reference

Keri Wellington

1

1 reference

7 August 2017

Karen L Goa

series ordinal

2

1 reference

7 August 2017

publication date

1 January 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

63

1 reference

7 August 2017

issue

19

1 reference

7 August 2017

page(s)

2107-2126

1 reference

Measles-mumps-rubella vaccine and autism: the rise (and fall?) of a hypothesis.

7 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200363190-00012

Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385

21 January 2018

1 reference

12 December 2020

Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 y of age

1 reference

12 December 2020

Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age.

1 reference

12 December 2020

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

1 reference

12 December 2020

Neurologic disorders after measles-mumps-rubella vaccination.

1 reference

12 December 2020

Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella

1 reference

12 December 2020

1 reference

12 December 2020

Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases

1 reference

12 December 2020

MMR immunization and autism.

1 reference

12 December 2020

Epidemiology of measles, mumps and rubella in Italy

1 reference

12 December 2020

A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children

1 reference

12 December 2020

No evidence for a new variant of measles-mumps-rubella-induced autism

1 reference

12 December 2020

Rational use of measles, mumps and rubella (MMR) vaccine

1 reference

12 December 2020

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study

1 reference

12 December 2020

Measles elimination in the Americas. Evolving strategies

1 reference

12 December 2020

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

12 December 2020

Mumps and mumps vaccine: a global review

1 reference

12 December 2020

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

1 reference

12 December 2020

The Unfinished Measles Immunization Agenda

1 reference

12 December 2020

Evidence of persistent measles virus infection in Crohn's disease

1 reference

12 December 2020

Prevalence of autism and parentally reported triggers in a north east London population

1 reference

12 December 2020

1 reference

12 December 2020

Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines

1 reference

12 December 2020

A national measles epidemic in Switzerland in 1997 : consequences for the elimination of measles by the year 2007

1 reference

12 December 2020

Scottish expert group finds no link between MMR and autism

1 reference

12 December 2020

Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy

1 reference

12 December 2020

Measles in Europe in 2001-2002

1 reference

12 December 2020

Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany

1 reference

12 December 2020

Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence

1 reference

12 December 2020

Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design.

1 reference

12 December 2020

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

1 reference

12 December 2020

Progress in reducing global measles deaths

1 reference

12 December 2020

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

1 reference

12 December 2020

A population-based study of measles, mumps, and rubella vaccination and autism

1 reference

12 December 2020

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

1 reference

12 December 2020

The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997

1 reference

12 December 2020

WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide

1 reference

12 December 2020

Measles vaccine: a 27-year follow-up

1 reference

12 December 2020

Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children

1 reference

12 December 2020

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project

1 reference

12 December 2020

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

1 reference

12 December 2020

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

12 December 2020

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

1 reference

12 December 2020

MMR and autism: further evidence against a causal association.

1 reference

12 December 2020

A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.

1 reference

12 December 2020

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

1 reference

12 December 2020

Measles elimination: progress and challenges

1 reference

12 December 2020

Measles, mumps, rubella vaccine: through a glass, darkly

1 reference

12 December 2020

Consequences of delayed measles vaccination in Germany.

1 reference

12 December 2020

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

1 reference

12 December 2020

10.2165/00003495-200363190-00012

Identifiers

DOI

1 reference

Dimensions Publication ID

7 August 2017

1030953015

0 references

1 reference